pubmed-article:2829276 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2829276 | lifeskim:mentions | umls-concept:C0014644 | lld:lifeskim |
pubmed-article:2829276 | lifeskim:mentions | umls-concept:C0001175 | lld:lifeskim |
pubmed-article:2829276 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:2829276 | lifeskim:mentions | umls-concept:C0007634 | lld:lifeskim |
pubmed-article:2829276 | lifeskim:mentions | umls-concept:C0229671 | lld:lifeskim |
pubmed-article:2829276 | lifeskim:mentions | umls-concept:C0596402 | lld:lifeskim |
pubmed-article:2829276 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
pubmed-article:2829276 | lifeskim:mentions | umls-concept:C0449435 | lld:lifeskim |
pubmed-article:2829276 | lifeskim:mentions | umls-concept:C0332167 | lld:lifeskim |
pubmed-article:2829276 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:2829276 | pubmed:dateCreated | 1988-3-2 | lld:pubmed |
pubmed-article:2829276 | pubmed:abstractText | Serologic reactivity against EBV-infected lines was assayed in patients with AIDS (n = 4) or the AIDS related complex (AIDS-RC) (n = 46) residing in Argentina. Anti-VCA serology was comparable to that of controls. However sera from AIDS and AIDS-RC could induce antibody dependent cell mediated cytotoxicity (ADCC) to EBV-infected cell lines (P3HRIK and Raji). ADCC activity could be recovered in the high molecular weight fractions of AIDS and AIDS-RC sera. ADCC was observed in sera with high levels of PEG precipitable material (PEG-pp) but was unrelated to the presence of complement-fixing immune complexes (Clq-F) or to anti-VCA titers. Fc receptor (FcR) bridging between target cells FcR and effector cells FcR may play a role in the outcome of total ADCC. | lld:pubmed |
pubmed-article:2829276 | pubmed:language | spa | lld:pubmed |
pubmed-article:2829276 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2829276 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2829276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2829276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2829276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2829276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2829276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2829276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2829276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2829276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2829276 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2829276 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2829276 | pubmed:issn | 0325-7541 | lld:pubmed |
pubmed-article:2829276 | pubmed:author | pubmed-author:de BraccoM... | lld:pubmed |
pubmed-article:2829276 | pubmed:author | pubmed-author:RieraN ENE | lld:pubmed |
pubmed-article:2829276 | pubmed:author | pubmed-author:FejesMM | lld:pubmed |
pubmed-article:2829276 | pubmed:author | pubmed-author:ScaglioniGG | lld:pubmed |
pubmed-article:2829276 | pubmed:author | pubmed-author:De la... | lld:pubmed |
pubmed-article:2829276 | pubmed:author | pubmed-author:Pérez... | lld:pubmed |
pubmed-article:2829276 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2829276 | pubmed:volume | 17 | lld:pubmed |
pubmed-article:2829276 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2829276 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2829276 | pubmed:pagination | 137-43 | lld:pubmed |
pubmed-article:2829276 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:meshHeading | pubmed-meshheading:2829276-... | lld:pubmed |
pubmed-article:2829276 | pubmed:year | 1985 | lld:pubmed |
pubmed-article:2829276 | pubmed:articleTitle | [Cytotoxicity induced by the serum of patients with AIDS and at high risk of AIDS against cells infected with Epstein-Barr virus]. | lld:pubmed |
pubmed-article:2829276 | pubmed:affiliation | Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina. | lld:pubmed |
pubmed-article:2829276 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2829276 | pubmed:publicationType | English Abstract | lld:pubmed |
pubmed-article:2829276 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2829276 | lld:pubmed |